86 reports

HIV/ AIDS Infection: An Opportunity for Enteral Feeding Devices Market A Peek at Global HIV Statistics Table ##: People Living with HIV Infection (in Million) by Region for 2016 (includes corresponding Graph/ Chart) Table ##: New HIV Infections Wo

  • Diabetes
  • United States
  • World
  • Company Sales
  • Market Segment
  • Global diabetic gastroparesis drugs market 2016-2021 ($ millions)
  • DIABETIC GASTROPARESIS

The number is much higher than many other diseases such as human immunodeficiency virus and acquired immune deficiency syndrome (HIV/ AIDS), tuberculosis, or malaria.

  • Diabetes
  • Forecast
  • Cadila Healthcare Ltd
  • GlaxoSmithKline plc
  • Valeant Pharmaceuticals International, Inc.

HIV/ AIDS, TUBERCULOSIS AND MALARIA).

  • Diabetes
  • Asia
  • Forecast
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.

He is experienced in designing and executing operational research study on HIV/ AIDS services uptake among high risk groups (HRGs) in India.

  • Diabetes
  • France
  • Germany
  • Spain
  • Forecast

It offers products in various therapeutic areas such as women' s health, children' s health, cardiovascular, dermatology and cosmeceuticals, diabetes, HIV-AIDS, hepatitis, infectious diseases, oncology, critical care, malaria, neurosciences, ophthalmology, osteoporosis, res

  • Diabetes
  • World
  • Actavis plc
  • AMAG Pharmaceuticals, Inc.
  • Vifor Pharma

The company offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, drug metabolism disorder, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/ AIDS, h

  • Diabetes
  • Asia
  • Europe
  • Forecast
  • Roche Group

HE IS EXPERIENCED IN DESIGNING AND EXECUTING OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Diabetes
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

HIV AND AIDS AND THOSE USED FOLLOWING ORGAN TRANSPLANTATION (ADA, 2016).

  • Diabetes
  • Asia
  • World
  • Novo Nordisk Group
  • Sanofi S.A.
  • CHAPTER III DIABETES DRUGS INDUSTRY ASSESSMENTS

EACH YEAR, DIABETES-RELATED Technology Development Chapter III DIABETES DRUGS INDUSTTY ASSESSMENTS CAUSES ACCOUNT FOR ##. ## MILLION DEATHS AND CLAIM THE LIVES OF AS MANY PEOPLE AS HIV/ AIDS.

  • Diabetes
  • China
  • Bayer AG
  • Novo Nordisk Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.

HOFFMANN-LA ROCHE AG The company offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, drug metabolism disorder, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV&

  • Diabetes
  • World
  • Abbott
  • ARKRAY, Inc.
  • Bayer AG

HIV/ AIDS, Road Injuries, Tuberculosis, Hypertensive Heart Disease) Table ##-##: Categories for Blood Pressure Levels in Adults Table ##-##: Interpretation of PT and PTT Levels in Adults Table ##-##: Oxygen Saturation Levels and Normal Heart Rates by Age ##: Competitor Trends and M

  • Diabetes
  • Patient Monitoring
  • Telemedicine
  • World
  • Forecast

EACH YEAR, DIABETES-RELATED Technology Development Chapter III DIABETES DRUGS INDUSTTY ASSESSMENTS CAUSES ACCOUNT FOR ##. ## MILLION DEATHS AND CLAIM THE LIVES OF AS MANY PEOPLE AS HIV/ AIDS.

  • Diabetes
  • China
  • Bayer AG
  • Beijing Taiyang Pharmaceutical Group
  • Novo Nordisk Pharmaceutical Co., Ltd.

However, there is continued growth in the number of AIDS patients (and in patients living with HIV infection) as a result of improved therapy and expansion in access to anti-retroviral therapy, which have helped to reduce the number of people dying from AIDS.

  • Diabetes
  • World
  • Cepheid
  • Hologic, Inc.
  • Roche Group

HE IS EXPERIENCED IN DESIGNING AND EXECUTING OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Diabetes
  • Japan
  • United Kingdom
  • United States
  • Forecast

THE REPORT FURTHER ESTIMATED THAT ##. ##% OF HEPATITIS B, ##. ##% OF HEPATITIS C AND ##. ##% OF HIV/ AIDS CASES IN HEALTHCARE WORKERS AROUND THE WORLD WERE FOUND TO BE DUE TO NEEDLESTICK INJURIES.

  • Diabetes
  • Injectable Delivery
  • Neurological Disorder
  • Demand
  • Market Size
  • 2.12 - BRAZIL SMBG MARKET

Brazil directly reimburses medicines used in the Single Health System (SUS) state hospitals for inpatients as well as for essential and exceptional medicines for outpatients in targeted disease groups such as HIV/ AIDS, cancer, diabetes and other common conditions such as endom

  • Diabetes
  • Europe
  • Forecast
  • Bayer AG
  • Medtronic, Inc.

PRIOR TO JOINING GLOBALDATA, NATASHA WORKED AS AN EPIDEMIOLOGIST FOR THREE YEARS IN THE HIV/ AIDS SURVEILLANCE PROGRAM AT THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH (MDPH).

  • Diabetes
  • Europe
  • Japan
  • Conatus Pharmaceuticals Inc.
  • Gilead Sciences, Inc.
  • GLOBAL CAUSES OF DEATH, 2014 ESTIMATES
  • Diabetes
  • World
  • DexCom, Inc.
  • Fitbit, Inc.
  • Omron Corporation

HE IS EXPERIENCED IN DESIGNING AND EXECUTING OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Diabetes
  • Japan
  • FirstString Research, Inc.
  • Organogenesis, Inc.
  • Smith & Nephew Plc

s BD Biosciences launched a new point-of-care system for HIV/ AIDS patients in April 2014.

  • Diabetes
  • World
  • Baxter International Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group

THESE TECHNOLOGIES ARE CAPABLE OF TRANSFORMING PEPTIDES INTO DRUGS WITH ENHANCED THERAPEUTIC PROPERTIES TO TREAT VARIOUS INDICATIONS INCLUDING DIABETES AND HIV / AIDS.

  • Diabetes
  • Endocrine Disease
  • United States
  • LipimetiX Development LLC
  • Novartis AG

It is estimated that in 2012 more than ##, ## people in China were infected by HIV and nearly ##, ## people died due to AIDS.

  • Diabetes
  • Asia
  • China
  • Market Size
  • Novo Nordisk Group

HIV/ AIDS Infection: An Opportunity for Parenteral Nutrition Market Persistent Threat of HIV/ AIDS - A Peek at Global HIV Statistics Table ##: People Living with HIV Infection (in Million) by Region for 2016 (includes corresponding Graph&

  • Diabetes
  • Europe
  • United States
  • World
  • Company Sales

The company' s target therapeutic areas include rheumatoid arthritis, HIV/ AIDS, respiratory infections, cancer, diabetes, men' s and women' s health, and genetic conditions.

  • Diabetes
  • Laboratory
  • Urine Test
  • World
  • Sysmex Corporation

HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution GDCT## NCT##, NCRR-

  • Clinical Trial
  • Diabetes
  • Insulin
  • United States
  • World
  • Type 2 Diabetes Mellitus, Global, Pipeline Programs Targeting Alpha Synuclein, 2016
  • 4.2 Classification of Diabetes Mellitus
  • Diabetes
  • Insulin
  • Pathology
  • Type 2 Diabetes
  • World

ELISA is widely used for the diagnosis of HIV/ AIDS (human immunodeficiency virus-acquired immunodeficiency syndrome), owing to the highly-sensitive nature of these assays.

  • Autoimmune Disease
  • Diabetes
  • Diagnostics
  • World
  • Market Size

HIV/ AIDS and infectious diseases Joint venture agreement for new product line Joint venture agreement for TG##, TG##, TG## and TG## development Collaboration agreement for life sciences investment No Jul 2012 Cannabis Science, Dupetit Natural Products Tasly Pharmaceuti

  • Biotech
  • Diabetes
  • Pharmaceutical
  • Deals & Alliance
  • Wildwood Ventures Limited

MARKETLINE FINANCIAL DEALS Vendor, acquirer, target and partner report for Temasek Holdings (Private) Limited and its subsidiaries.

  • Cardiology
  • Diabetes
  • Healthcare
  • Pharmaceutical
  • Temasek Group

In February 2010, Bach Pharma, Inc filed a patent with the application (US##) entitled with Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS".

  • Chronic Disease
  • Diabetes
  • United States
  • Product Initiative
  • RPI